EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Management of Lung Cancer in the Patient with Interstitial Lung Disease

Angela J Frank, Ibiayi Dagogo-Jack, Ioana A Dobre, Sarah Tait, Lana Schumacher, Florian J Fintelmann, Leah M Fingerman, Florence K Keane, Sydney B Montesi iD

The Oncologist · 18.01.2023 · 28 (1) · 12-22

DOI: 10.1093/oncolo/oyac226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Oncologist, online erschienen am 25.11.2022. Verfasst von Angela J Frank und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Lung Neoplasms, Lung Diseases, Interstitial, Pneumonia. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with interstitial lung disease (ILD), especially those with pulmonary fibrosis, are at increased risk of developing lung cancer. Management of lung cancer in patients with ILD is particularly challenging. Diagnosis can be complicated by difficulty differentiating lung nodules from areas of focal fibrosis, and percutaneous biopsy approaches confer an increased risk of complications in those with pulmonary fibrosis. Lung cancer treatment in these patients pose several specific considerations. The degree of lung function impairment may preclude lobectomy or surgical resection of any type. Surgical resection can trigger an acute exacerbation of the underlying ILD. The presence of ILD confers an increased risk of pneumonitis with radiotherapy, and many of the systemic therapies also carry an increased risk of pneumonitis in this population. The safety of immunotherapy in the setting of ILD remains to be fully elucidated and concerns remain as to triggering pneumonitis. The purpose of this review is to summarize the evidence regarding consideration for tissue diagnosis, chemotherapy and immunotherapy, radiotherapy, and surgery, in this patient population and discuss emerging areas of research. We also propose a multidisciplinary approach and practical considerations for monitoring for ILD progression during lung cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisLung NeoplasmsLung Diseases, InterstitialPneumoniaHumansLung

Stichwörter der Autor:innen

Interstitial lung diseaseLung cancerPneumonitis

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
  • Queen's University School of Medicine, Kingston, ON, Canada.
  • Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.

ORCID-Profile: Sydney B Montesi

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Frank, A. J., Dagogo-Jack, I., Dobre, I. A., Tait, S., Schumacher, L., Fintelmann, F. J., Fingerman, L. M., Keane, F. K., & Montesi, S. B. (2023). Management of Lung Cancer in the Patient with Interstitial Lung Disease. The Oncologist, 28(1), 12-22. https://doi.org/10.1093/oncolo/oyac226

Vancouver

Frank AJ, Dagogo-Jack I, Dobre IA, Tait S, Schumacher L, Fintelmann FJ, et al. Management of Lung Cancer in the Patient with Interstitial Lung Disease. The Oncologist. 2023;28(1):12-22. doi:10.1093/oncolo/oyac226

BibTeX
@article{Frank2023,
  author = {Frank, Angela J and Dagogo-Jack, Ibiayi and Dobre, Ioana A and Tait, Sarah and Schumacher, Lana and Fintelmann, Florian J and Fingerman, Leah M and Keane, Florence K and Montesi, Sydney B},
  title = {Management of Lung Cancer in the Patient with Interstitial Lung Disease},
  journal = {The Oncologist},
  year = {2023},
  volume = {28},
  number = {1},
  pages = {12--22},
  doi = {10.1093/oncolo/oyac226}
}
Kostenlos starten →